Sign In
Buy CHRS
$1.46
-0.0200 (-1.35%)
At Close: Jun 23, 2026
Envestnet Asset Management Inc. Purchases 2,476 Shares of Coherus Biosciences Inc (NASDAQ:CHRS)
10:10am, Thursday, 26'th Mar 2020
Envestnet Asset Management Inc. boosted its position in Coherus Biosciences Inc (NASDAQ:CHRS) by 5.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Se
Mizuho Securities Keeps a Buy Rating on Coherus Biosciences (CHRS)
01:53am, Thursday, 26'th Mar 2020
Mizuho Securities analyst Salim Syed maintained a Buy rating on Coherus Biosciences (CHRS) yesterday and set a price target of $35.00. The company's
Mizuho Securities Keeps a Buy Rating on Coherus Biosciences (CHRS)
01:53am, Thursday, 26'th Mar 2020
Mizuho Securities analyst Salim Syed maintained a Buy rating on Coherus Biosciences (CHRS – Research Report) yesterday and set a
In Biotech ‘Cash Is King’ When Wall Street Searches for Value
06:04pm, Wednesday, 25'th Mar 2020
(Bloomberg) -- For investors looking for deals in biotech, Wall Street firms like Baird advise “cash is king.”Losses in the U.S. stock market have decimated many portfolios. And while biotechnolog
Selloff creating bargains in healthcare - Baird
05:54pm, Wednesday, 25'th Mar 2020
Stating the obvious, Baird analysts have created three lists of healthcare companies that may be worth a look considering their attractive valuations or relatively strong capitalizations amid the COVI
Coherus Biosciences (NASDAQ:CHRS) Trading Up 14.3%
09:22am, Wednesday, 25'th Mar 2020
Coherus Biosciences Inc (NASDAQ:CHRS) was up 14.3% during mid-day trading on Tuesday . The stock traded as high as $16.74 and last traded at $16.26, approximately 1,467,417 shares changed hands during
Market Still Sliding While Waiting For Congress
01:15pm, Tuesday, 24'th Mar 2020
Market Still Sliding While Waiting For Congress
Wall Street Analysts Are Bullish on Top Healthcare Picks
08:19am, Tuesday, 24'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aerie Pharma (AERI) and Gilead Sciences (GILD) with bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
08:19am, Tuesday, 24'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aerie Pharma
Oxford Asset Management LLP Purchases New Position in Coherus Biosciences Inc (NASDAQ:CHRS)
12:48pm, Monday, 23'rd Mar 2020
Oxford Asset Management LLP purchased a new stake in Coherus Biosciences Inc (NASDAQ:CHRS) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purcha
AlphaCrest Capital Management LLC Takes $278,000 Position in Coherus Biosciences Inc (NASDAQ:CHRS)
09:46am, Monday, 23'rd Mar 2020
AlphaCrest Capital Management LLC purchased a new stake in Coherus Biosciences Inc (NASDAQ:CHRS) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities
Coherus Biosciences Inc (NASDAQ:CHRS) Shares Sold by Credit Suisse AG
11:40am, Saturday, 21'st Mar 2020
Credit Suisse AG decreased its holdings in Coherus Biosciences Inc (NASDAQ:CHRS) by 26.4% in the fourth quarter, Holdings Channel reports. The firm owned 283,167 shares of the biotechnology company’
Coherus BioSciences Announces New Employment Inducement Grants
01:30pm, Friday, 20'th Mar 2020
REDWOOD CITY, Calif., March 20, 2020 -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective March 19, 2020, the compensation.
Coherus BioSciences Announces New Employment Inducement Grants
01:30pm, Friday, 20'th Mar 2020
REDWOOD CITY, Calif., March 20, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that...
Citigroup Inc. Cuts Holdings in Coherus Biosciences Inc (NASDAQ:CHRS)
10:18am, Friday, 20'th Mar 2020
Citigroup Inc. trimmed its holdings in shares of Coherus Biosciences Inc (NASDAQ:CHRS) by 50.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchan
